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Abstract
Background:  The signal peptide plays an important role in protein targeting and protein
translocation in both prokaryotic and eukaryotic cells. This transient, short peptide sequence
functions like a postal address on an envelope by targeting proteins for secretion or for transfer to
specific organelles for further processing. Understanding how signal peptides function is crucial in
predicting where proteins are translocated. To support this understanding, we present SPdb signal
peptide database http://proline.bic.nus.edu.sg/spdb, a repository of experimentally determined and
computationally predicted signal peptides.
Results: SPdb integrates information from two sources (a) Swiss-Prot protein sequence database
which is now part of UniProt and (b) EMBL nucleotide sequence database. The database update is
semi-automated with human checking and verification of the data to ensure the correctness of the
data stored. The latest release SPdb release 3.2 contains 18,146 entries of which 2,584 entries are
experimentally verified signal sequences; the remaining 15,562 entries are either signal sequences
that fail to meet our filtering criteria or entries that contain unverified signal sequences.
Conclusion: SPdb is a manually curated database constructed to support the understanding and
analysis of signal peptides. SPdb tracks the major updates of the two underlying primary databases
thereby ensuring that its information remains up-to-date.
Background
Günter Blobel discovered that "proteins have intrinsic sig-
nals that govern their transport and localization in the
cell" [1]. Proteins synthesised at the ribosome (cytoplasm
or rough endoplasmic reticulum), mitochondria or chlo-
roplast are transported to their site of function. This proc-
ess is known as protein targeting and it depends on
targeting signals to direct the proteins to their specific
locations.
There are many different classes of targeting signals. One
of the commonly occurring signals is formed by short,
transient peptides known as signal peptides or leader
sequences, which are usually found at the amino terminus
of secreted proteins. Signal peptides are present in both
prokaryotic and eukaryotic cells, indicating its ancient
universal origins. They function like a postal address label
on an envelope by targeting the proteins for secretion or
to specific organelle for further processing. The signal pep-
tides are cleaved off and degraded upon reaching their tar-
geted locations. Interestingly, not all proteins possess
signal peptides [2,3], suggesting that other mechanisms
for protein targeting exist.
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Over the years, several prediction tools [4-10] have been
developed to predict the cleavage sites of signal peptides.
These prediction tools require training and testing data-
sets. As a preparatory step for prediction work, researchers
often devote considerable time sifting through primary
databases such as Swiss-Prot [11], EMBL [12] and other
databases to collate and construct their own datasets. This
repetitive process can and should be eliminated by creat-
ing a centralised repository of signal peptide sequences.
Searching through popular search engines and reviewing
the Nucleic Acids Research database list [13] reveal several
databases that provide information on protein subcellular
localisation [14,15], nuclear proteins [16] and secreted
proteins [17]. These databases do not provide signal pep-
tide specific information except for SPD [17]. SPD or
secreted protein database [17] is a collection of proteins
from the human, mouse and rat proteomes originating
from databases such as TrEMBL [18], Ensembl [19] and
Refseq [20]. It also includes datasets from the Secreted
Protein Discovery Initiative (SPDI) [21], a large-scale
effort to identify novel human secreted and transmem-
brane proteins; the Riken mouse secretome and seven
other related datasets [22]. SPD aims to be a comprehen-
sive repository for secreted proteins, but it suffers from
providing datasets that may still contain many erroneous
annotations from its underlying data sources for example
TrEMBL. TrEMBL is generated from an automated pipe-
line and has yet to undergo manual curation. In addition,
the entries in SPD were not checked manually against the
publications. Then, there is also the issue that the datasets
are not being updated.
Besides the SPD which offer downloadable datasets, there
are sites that offer downloadable datasets namely the Sig-
nalP datasets (1997) [10,23] and the datasets (2000) used
by Meene et al. [24,25] in their evaluation of signal pep-
tide prediction methods. More recently, there is the data-
set consisting of 270 secreted recombinant human
proteins with experimentally determined cleavage sites
from Zhang and Henzel [26,27]. These datasets are often
either limited in size or otherwise lacking in tools for que-
rying the datasets. Moreover, these datasets although val-
uable but they are often outdated [28] especially when
GenBank/EMBL, Swiss-Prot and other publicly accessible
primary databases continue to churn out new entries or
sequences.
Many researchers are confronted by similar obstacles in
accessing up-to-date data, which are withheld from public
access by method developers [29,30] and hence, we
strongly believe that there is a urgent need to provide a
publicly-accessible, manually curated and regularly
updated database specialised for signal peptides. These
datasets will not only be important for prediction work
but they will also serve as the common datasets needed
when researchers are performing benchmarking against
each other methods or programs, without which we think
it is difficult to perform proper or fair benchmarking of
the multitudes of prediction methods.
Construction and content
Construction and implementation of database
Recognizing the need for a curated, specialised and up-to-
date database, we have developed a composite signal pep-
tide database SPdb [31] that offers researchers a singular
point for depositing their signal peptide annotations.
SPdb integrates information from Swiss-Prot (part of Uni-
Prot) [18] and EMBL. It is updated when there is a major
release of Swiss-Prot. First released in May 2004, SPdb was
upgraded to release 3.2 recently to add on new features
and to synchronise with the release of its underlying data
sources.
SPdb is a relational database built using MySQL database
management system [32] and using PERL/CGI [33] for
processing web forms. An easy-to-navigate web interface
was built to allow user to search through the database.
Some of the web features were added in response to the
requests by some of the users that have used our database
since its inception. Through the web interface, users are
able to download the returned results as FASTA formatted
files or view the results as HTML web page. We have also
provided a link from the search page to the Swiss-Prot ID
tracker to verify whether an entry has been renamed e.g.
ANL3_HUMAN from the Zhang and Henzel dataset [27],
which is now ANGL3_HUMAN.
We deployed the bioinformatics pipeline shown in (Fig-
ure 1) to construct SPdb. The pipeline to construct the
database was semi-automated with specific checkpoints
for manual checking of the results to minimise errors in
the database.
Construction method
Signal sequences and coding sequences obtained from
Swiss-Prot (TrEMBL entries were not taken into consider-
ation) were filtered initially using the data extraction and
redundancy reduction methodology proposed by Nielsen
et al. [34] to segregate the dataset into two sets (a) the pre-
liminary filtered set and (b) the unverified sequences set. The
Nielsen et al. [34] methodology has been employed to
generate the training and testing data used in SignalP
[10,35]. We adapted and omitted some of the criteria pro-
posed by the method since our goal is to build a reposi-
tory of signal peptides with as many relevant and accurate
entries as possible. We observed that the proposed meth-
odology still renders many undesirable entries upon the
filtering process. Thus, we have constructed SPdb by
building on the strength of the proposed methodologyBMC Bioinformatics 2005, 6:249 http://www.biomedcentral.com/1471-2105/6/249
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[34] and improved it with our own criteria and filtering
rules.
Any entries with the SIGNAL keyword indicated in the fea-
ture table FT field [36] of Swiss-Prot entries were pre-
sumed to contain information on signal sequence. This
simple selection process yielded 18,146 entries out of the
total 170,140 Swiss-Prot entries (Release 46.1). Entries
that connoted uncertainty namely those with annotations
like PROBABLE, POTENTIAL, BY SIMILARITY, HYPO-
THETICAL and entries with ambiguous cleavage or signal
peptide positions were tagged as unverified sequences.
Then, entries with signal sequences length less than 11
were relegated to the unverified sequences set. Signal
sequences are generally considered to be of length 15 to
40. This initial step filtered off 13,701 entries from the pre-
liminary filtered set leaving behind 4,445 entries. These
entries include type I signal peptides, type II signal pep-
tides (lipoproteins) and TAT-containing signal peptides.
Using the SIGNAL keyword, mitochondria and chloro-
plast transit peptides were excluded from the preliminary
set since transit peptides are identified by the TRANSIT
keyword in Swiss-Prot.
We proceeded to integrate information from the EMBL
database. By integrating complementary information,
besides providing extra information not found in Swiss-
Prot, we could use the information from EMBL to cross
check against Swiss-Prot, allowing us to discover errone-
ous annotations. This practice of using complementary
information from other data sources has been found use-
ful in data evaluation [37].
The first cross-reference entry to EMBL database was used
for the respective Swiss-Prot entry. Based on the data cate-
gorisation of EMBL found in its release note [38], only
sequences from the data groups fungi, human, inverte-
brate, mouse, organelle, bacteriophage, plant, prokaryote,
rodent, viral, mammals and vertebrate were taken into
consideration. Entries belonging to the data groups
expressed sequence tags, genome survey sequences, high-
throughput genome sequences, unfinished DNA
sequences generated by high-throughput sequencing, pat-
ent sequences, synthetic sequences, contig sequences and
unclassified were omitted. We extracted out relevant
annotations from EMBL whenever available including
coding sequence, signal sequence and its length, subcellu-
lar location, authors' notes and so on.
The annotations, specifically the sig_region and misc fields
from the EMBL entry were utilised in the subsequent step
to cross-check against the preliminary filtered entries. This
step again filtered out many inconsistent entries where the
positions are quoted wrongly by either source e.g. [Swiss-
Prot:CD166_CHICK] where Swiss-Prot quoted cleavage
position of 33 while EMBL provided 32. As a result,
another 866 entries were eliminated to retain 3,579
entries in this newly filtered Swiss-Prot/EMBL set. It must
be noted that there were some Swiss-Prot entries in the
Swiss-Prot/EMBL  set without any EMBL reference e.g.
[Swiss-Prot:APOE_CAVPO]; or with insufficient annota-
tions in the EMBL entries e.g. [Swiss-Prot:17KD_RICAU];
or their EMBL cross-references were indicated with anno-
tation such as NOT_ANNOTATED_CDS e.g. [Swiss-
Prot:2B31_HUMAN], ALT_TERM e.g. [Swiss-
Prot:CD1E_HUMAN], ALT_INIT e.g. [Swiss-
Prot:1A03_PANTR] and ALT_SEQ e.g. [Swiss-
Prot:17KD_RICPR]. In these cases, all these entries were
earmarked for manual curation. These terms
"NOT_ANNOTATED_CDS", "ALT_TERM" and so on are
known as status identifiers and they are found at the DR
field in Swiss-Prot entries. The reader is referred to the
detailed explanation found in the Swiss-Prot manual [39].
Following this step, all the entries in this Swiss-Prot/EMBL
set are manually checked against the referred publica-
tions. We located numerous entries with discrepancies on
signal peptide cleavage site between the Swiss-Prot anno-
tations and the accompanying papers e.g. [Swiss-
Prot:CECC_DROME, Swiss-Prot:AMCY_PARVE]. Entries
that we do not have access to the accompanying papers
e.g. [Swiss-Prot:ZEAL_MAIZE, Swiss-Prot:ZEA6_MAIZE]
or those entries that we could not locate their cleavage site
information in the papers e.g. [Swiss-Prot:GUX1_TRIRE];
these entries in addition to those entries which are inade-
quately labelled or entries with inconsistent positional
information were all relegated to the unverified sequences
set. In this manual curation step, we eliminated 995
entries from the Swiss-Prot/EMBL  set of 3,579 entries.
These 995 entries were entries that (a) both Swiss-Prot
and the quoted papers provided the same putative posi-
Table 1: Distribution of the signal sequences filtered out in the 
manual curation step
Description No. of Entries/Sequences
Swiss-prot and the accompanying
papers quoted same putative position
311
Swiss-Prot and the accompanying
papers quoted different position;
The position quoted maybe
confirmed or putative
100
No references or relevant references
were provided;
No access to some subscription-only
papers;
No access to some very old papers
194
Unable to locate or obtain the
position information from the papers
390
TOTAL 995BMC Bioinformatics 2005, 6:249 http://www.biomedcentral.com/1471-2105/6/249
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tion (b) we found differing positions quoted by Swiss-
Prot as compared to the quoted papers (c) we did not have
access to the quoted subscription-only papers or the
papers referred to were old and in some cases there were
no paper or no relevant paper quoted (d) we could not
find or locate the cleavage site information (Table 1).
Content of database
The result from filtering and manually curating the entries
culminated in the latest release of SPdb release 3.2, with a
total of 18,146 signal sequence entries, out of which
2,584 are filtered sequences (Table 2). These filtered
sequences, known as the filtered sequences set include the
mature endogenous proteins that were sequenced on their
N-terminal and have been checked against the accompa-
nying reference paper to be considered as experimentally
verified positions. The remaining 15,562 unverified
sequences  contain putative or experimentally unverified
cleavage site signal sequences. This unverified  set also
contains entries with erroneous database annotations. It is
worth noting that this unverified set might contain some
experimentally verified signal sequences since we may not
have access to the accompanying papers.
With the two primary databases integrated, SPdb contains
four data groups namely archaea, bacteria, eukaryotes and
viruses and (Table 2). SPdb provides key extracted infor-
mation (Figure 2) such as organism source, organelle,
subcellular location and other accompanying important
notes. For full annotation, cross-referenced links to the
originating database are provided. The signal peptide
cleavage site is explicitly marked if such information is
available. The signal peptide sequences and 30 residues
[40] after the cleavage site are colour-coded using the con-
vention as specified by RasMol amino acids colour
scheme [41] which is based on the traditional amino acid
properties. In the process of manually curating the 3,579
entries, we have added our own annotation for the 995
entries that were removed from this dataset later on.
Utility and discussion
SPdb provides users with an easy-to-use web interface
with flexibility to select for an entry or a collective set of
entries matching users' criteria such as name of organism,
data group, length of signal sequences, keyword searches
and more importantly the option to choose between
including or excluding certain entries. We have taken the
approach to allow users to omit or filter any sequences
since every user may have different requirements on the
returned results. Each of the entry will be indicated
whether it is verified or unverified (Figure 2).
In the process of creating SPdb, we realise that although
Swiss-Prot provides better quality annotation, it still con-
tains erroneous or conflicting annotations as evident
when we compare the positions or length of the signal
sequences reported by Swiss-Prot with EMBL e.g. [Swiss-
Prot:A2AP_HUMAN, Swiss-Prot:BTD_HUMAN]. We
notice that the inconsistencies usually arise when there is
more than one reference. The referred papers may quote
different positions thus this may have caused the confu-
sion. To help to resolve this issue, we have combined the
annotations from -EMBL, and we managed to identify and
filter off many such entries. The annotations on signal
peptide found in EMBL were mostly accurate though there
were cases when the information was reported incorrectly
as well e.g. [EMBL:M19077] in [Swiss-
Prot:CHR1_BOMMO]. In this respect, we have included a
link in each entry for users to report to us if they encounter
any errors or discrepancies in SPdb.
Apart from the errors and inconsistencies just described,
there was also the issue on experimental support from the
journal publication. Many of the entries with annotation
on signal sequences positions or length were predicted or
deemed putative or potential (Table 1) by the researchers
when they reported the positions in their papers. None-
theless, the entries were not labelled with words like
POTENTIAL, BY SIMILARITY and PROBABLE in the
Swiss-Prot entry as previously assumed. We learnt that
many of the referred papers were using prediction or
sequence alignment software to identify or suggest the
cleavage site of signal sequences. Therefore, we think it
would be more appropriate and useful if the references to
the papers were also indicated at the relevant fields so that
any users of the entries can easily check and read up on the
papers that mentioned about signal peptides or any other
features.
Table 2: Distribution of signal sequences in SPdb according to archaea (AR), bacteria (BA), viruses (VR) and eukaryotes (EU).
AR BA EU VR SUB-TOTAL
Verified sequences 7 540 1,945 92 2,584
Unverified sequences 101 3,528 11,239 694 15,562
TOTAL 108 4,068 13,184 786 18,146BMC Bioinformatics 2005, 6:249 http://www.biomedcentral.com/1471-2105/6/249
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All these issues and problems have made automation of
the construction of SPdb immensely difficult if not
remotely impossible. Prior to manually curating the
entries, we have considered using text-mining approach
but we forwent the method eventually when we discov-
ered that many of abstracts did not contain the cleavage
site information rather the information was found in the
body of the paper, usually located under the results or dis-
cussion section. Moreover, the words or phrases used to
express the positional information were also varying and
difficult to express as extraction rules e.g. in the paper [42]
quoted in entry [Swiss-Prot:PRRP_BOVIN], we encoun-
Schematic diagram of the construction pipeline of SPdb Figure 1
Schematic diagram of the construction pipeline of SPdb.BMC Bioinformatics 2005, 6:249 http://www.biomedcentral.com/1471-2105/6/249
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tered this sentence "... its N-terminal portion before Ser-
23 showed the typical profile of a secretory signal peptide
...". Then there is also the problem where many of the
papers require subscriptions, rendering the extraction pro-
gram useless unless we can obtain the papers. Unless each
of the paper submitted in future provides a short note on
the features of the proteins described coupled with the
improvement in text-mining accuracy, we will have to
resort to manual curation.
In SPdb, datasets are classified into filtered sequences and
unverified sequences. By classifying the entries into these
two classifications, researchers can use them in the work
of machine learning approaches, where datasets are
sought after as training and testing sets in signal peptide
cleavage site prediction.
Apart from facilitating test datasets, SPdb provides other
information such as amino acid composition of the pro-
tein which have been suggested to correlate with the sub-
cellular localisation of the protein [43]; amino acid
residues properties (aromatic, non-polar, polar, charged
and so on) are shown in graphical format to indicate
which residues possess the properties visibly; also accom-
panying each entry are the hydropathy plots based on
Kyte and Doolittle [44], Sweet and Eisenberg [45], Eisen-
berg et al. [46] of the signal sequences and the sequences
downstream of the signal sequence cleavage. The plots are
rendered using pepinfo within the computational analysis
SPdb entry information includes a short description of the protein, the hydropathy plots and amino acids properties and more Figure 2
SPdb entry information includes a short description of the protein, the hydropathy plots and amino acids properties and more. 
(A) Each entry is marked as verified or unverified, with (B) a "report-error" link for users to inform us on any error or updated 
information pertaining to an entry for us to rectify/update. (C) users can deposit their signal sequences with us and add on 
their own annotation.BMC Bioinformatics 2005, 6:249 http://www.biomedcentral.com/1471-2105/6/249
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package of EMBOSS [47], an open source software suite
for sequence analysis. Each signal peptide exhibits three
distinct regions at the sequence level: the n-region (a posi-
tive charged region), the h-region (hydrophobic region)
and the c-region  (polar and neutral region) [9]. The
hydropathy plots help to visualize and identify these
regions.
De Gier et al. [48] showed that signal peptide processing
by the signal recognition particle (SRP) requires certain
contextual cues in the sequence downstream. SRP binds to
N-terminus signal or signal-anchor sequence when the
nascent polypeptide chain is synthesised by the ribosome
up to ~60 amino acid residues. At this length, this segment
is conveniently exposed and translation will resume upon
dissociation of SRP from the nascent chain. In the effort to
capture this information for the co-translational translo-
cation mechanism, SPdb includes both the signal peptide
sequences and 30 residues after the cleavage site.
For the future releases, we hope to include other informa-
tion which maybe useful such as functional classification
of signal peptides according to target destination, the pro-
files of signal peptides from various organisms and so on.
As differentially targeted organelles or locations have var-
iations on the general theme of signal peptide target pro-
teins, we would like to include these different targeting
signals for comparison and studies. Concerning secreted
proteins that lack cleavable signal peptide [49] e.g. oval-
bumin, a secreted glycoprotein and the major protein of
egg-white which does not have a cleavable signal peptide
[50], we would like to include this information and ana-
lyse how they differ from those proteins with cleavable
signal peptide.
Conclusion
Signal peptide plays an important role in the transport of
secretory proteins. Understanding of signal peptide recog-
nition and mechanisms of targeting, transport and trans-
location will unleash many applications in the area of
drug design and medicine. We have provided a freely
accessible, manually curated signal peptide database that
is regularly updated and synchronised with the release of
the two major primary databases, Swiss-Prot and EMBL.
By integrating information from both databases, SPdb is
able to eliminate some of the discrepancies and minimise
the errors found in the sequence entries, thereby provid-
ing a better quality of the downloadable datasets that can
be used by the research community for prediction work
and other research.
Availability and requirements
SPdb is freely accessible through the website http://pro
line.bic.nus.edu.sg/spdb. We have made available a dedi-
cated page to allow user to download the dataset in full
based on certain criteria available to user.
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